YS Biopharma Co Ltd
NASDAQ:YS
Income Statement
Earnings Waterfall
YS Biopharma Co Ltd
Revenue
|
960.3m
CNY
|
Cost of Revenue
|
-205.5m
CNY
|
Gross Profit
|
754.7m
CNY
|
Operating Expenses
|
-1.1B
CNY
|
Operating Income
|
-322.6m
CNY
|
Other Expenses
|
-135.4m
CNY
|
Net Income
|
-458m
CNY
|
Income Statement
YS Biopharma Co Ltd
Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue |
0
N/A
|
503
N/A
|
0
N/A
|
0
N/A
|
687
N/A
|
960
+40%
|
|
Gross Profit | |||||||
Cost of Revenue |
0
|
(117)
|
0
|
0
|
(153)
|
(206)
|
|
Gross Profit |
0
N/A
|
386
N/A
|
0
N/A
|
0
N/A
|
534
N/A
|
755
+41%
|
|
Operating Income | |||||||
Operating Expenses |
(1)
|
(505)
|
5
|
2
|
(673)
|
(1 077)
|
|
Selling, General & Administrative |
(1)
|
(294)
|
(1)
|
(2)
|
(355)
|
(580)
|
|
Research & Development |
0
|
(211)
|
0
|
0
|
(319)
|
(498)
|
|
Other Operating Expenses |
(0)
|
0
|
6
|
4
|
0
|
0
|
|
Operating Income |
(1)
N/A
|
(119)
-21 264%
|
5
N/A
|
2
-53%
|
(139)
N/A
|
(323)
-131%
|
|
Pre-Tax Income | |||||||
Interest Income Expense |
(3)
|
(3)
|
(0)
|
1
|
(31)
|
(44)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
7
|
0
|
0
|
|
Total Other Income |
3
|
21
|
8
|
7
|
26
|
47
|
|
Pre-Tax Income |
(1)
N/A
|
(101)
-18 420%
|
13
N/A
|
18
+36%
|
(144)
N/A
|
(320)
-121%
|
|
Net Income | |||||||
Tax Provision |
0
|
(5)
|
0
|
0
|
(1)
|
(0)
|
|
Income from Continuing Operations |
(1)
|
(106)
|
13
|
18
|
(145)
|
(320)
|
|
Net Income (Common) |
(1)
N/A
|
(237)
-43 267%
|
13
N/A
|
18
+36%
|
(283)
N/A
|
(458)
-62%
|
|
EPS (Diluted) |
-0.03
N/A
|
-2.54
-8 367%
|
0.5
N/A
|
0.69
+38%
|
-3.05
N/A
|
-4.92
-61%
|